| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 7.02e-06 | 276 | 10 | 4 | GO:0003730 | |
| GeneOntologyMolecularFunction | mRNA binding | 1.09e-05 | 694 | 10 | 5 | GO:0003729 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 1.92e-04 | 42 | 10 | 2 | GO:0140693 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 3.84e-04 | 303 | 10 | 3 | GO:0003713 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 1.79e-03 | 1160 | 10 | 4 | GO:0030674 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 1.94e-03 | 134 | 10 | 2 | GO:0003697 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 2.30e-03 | 562 | 10 | 3 | GO:0003712 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 3.19e-03 | 1356 | 10 | 4 | GO:0060090 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 3.74e-03 | 187 | 10 | 2 | GO:0016922 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.75e-02 | 417 | 10 | 2 | GO:0061629 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 3.27e-02 | 582 | 10 | 2 | GO:0140297 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 1.37e-06 | 917 | 10 | 6 | GO:0016071 | |
| GeneOntologyBiologicalProcess | RNA splicing | 1.91e-06 | 502 | 10 | 5 | GO:0008380 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 1.73e-05 | 358 | 10 | 4 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.73e-05 | 358 | 10 | 4 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 1.80e-05 | 362 | 10 | 4 | GO:0000375 | |
| GeneOntologyBiologicalProcess | mRNA transport | 3.94e-05 | 145 | 10 | 3 | GO:0051028 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 3.98e-05 | 443 | 10 | 4 | GO:1903311 | |
| GeneOntologyBiologicalProcess | RNA transport | 6.90e-05 | 175 | 10 | 3 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 6.90e-05 | 175 | 10 | 3 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 7.25e-05 | 178 | 10 | 3 | GO:0051236 | |
| GeneOntologyBiologicalProcess | mRNA processing | 9.31e-05 | 551 | 10 | 4 | GO:0006397 | |
| GeneOntologyBiologicalProcess | RNA localization | 1.31e-04 | 217 | 10 | 3 | GO:0006403 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 1.96e-04 | 249 | 10 | 3 | GO:0015931 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 3.70e-04 | 309 | 10 | 3 | GO:0061013 | |
| GeneOntologyBiologicalProcess | RNA processing | 3.73e-04 | 1500 | 10 | 5 | GO:0006396 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 4.60e-04 | 333 | 10 | 3 | GO:0051054 | |
| GeneOntologyBiologicalProcess | mRNA export from nucleus | 5.61e-04 | 74 | 10 | 2 | GO:0006406 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 6.41e-04 | 373 | 10 | 3 | GO:0006402 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 9.22e-04 | 95 | 10 | 2 | GO:2000781 | |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 9.42e-04 | 96 | 10 | 2 | GO:0006405 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 9.81e-04 | 432 | 10 | 3 | GO:0006401 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 1.21e-03 | 464 | 10 | 3 | GO:0141188 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 1.35e-03 | 115 | 10 | 2 | GO:1903312 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 2.07e-03 | 143 | 10 | 2 | GO:0045739 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 2.11e-03 | 564 | 10 | 3 | GO:0051052 | |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 2.16e-03 | 146 | 10 | 2 | GO:2000779 | |
| GeneOntologyBiologicalProcess | nuclear export | 3.43e-03 | 185 | 10 | 2 | GO:0051168 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound catabolic process | 3.84e-03 | 696 | 10 | 3 | GO:0034655 | |
| GeneOntologyCellularComponent | spliceosomal complex | 2.18e-06 | 215 | 10 | 4 | GO:0005681 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 1.14e-05 | 97 | 10 | 3 | GO:0071013 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 1.35e-05 | 1377 | 10 | 6 | GO:0140513 | |
| GeneOntologyCellularComponent | nBAF complex | 2.46e-05 | 16 | 10 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | postsynaptic cytosol | 2.02e-04 | 45 | 10 | 2 | GO:0099524 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 2.86e-04 | 287 | 10 | 3 | GO:0035770 | |
| GeneOntologyCellularComponent | cytosolic region | 4.89e-04 | 70 | 10 | 2 | GO:0099522 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 9.17e-04 | 96 | 10 | 2 | GO:0070603 | |
| GeneOntologyCellularComponent | ATPase complex | 1.65e-03 | 129 | 10 | 2 | GO:1904949 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | 1.68e-03 | 1194 | 10 | 4 | GO:1990904 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 1.87e-03 | 1228 | 10 | 4 | GO:0036477 | |
| GeneOntologyCellularComponent | chromatin | 3.72e-03 | 1480 | 10 | 4 | GO:0000785 | |
| GeneOntologyCellularComponent | perikaryon | 4.82e-03 | 223 | 10 | 2 | GO:0043204 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 5.81e-03 | 817 | 10 | 3 | GO:0098978 | |
| GeneOntologyCellularComponent | dendrite | 6.66e-03 | 858 | 10 | 3 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 6.70e-03 | 860 | 10 | 3 | GO:0097447 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 6.94e-03 | 269 | 10 | 2 | GO:0036464 | |
| GeneOntologyCellularComponent | nuclear body | 7.67e-03 | 903 | 10 | 3 | GO:0016604 | |
| GeneOntologyCellularComponent | postsynapse | 1.07e-02 | 1018 | 10 | 3 | GO:0098794 | |
| GeneOntologyCellularComponent | chromosomal region | 1.64e-02 | 421 | 10 | 2 | GO:0098687 | |
| GeneOntologyCellularComponent | postsynaptic density | 1.86e-02 | 451 | 10 | 2 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 2.07e-02 | 477 | 10 | 2 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 2.29e-02 | 503 | 10 | 2 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 2.46e-02 | 523 | 10 | 2 | GO:0098984 | |
| HumanPheno | Proximal amyotrophy | 4.75e-05 | 58 | 7 | 3 | HP:0007126 | |
| HumanPheno | Motor neuron atrophy | 7.01e-05 | 66 | 7 | 3 | HP:0007373 | |
| MousePheno | chromosome breakage | 4.01e-04 | 62 | 7 | 2 | MP:0004028 | |
| MousePheno | abnormal forebrain morphology | 9.97e-04 | 1072 | 7 | 4 | MP:0000783 | |
| MousePheno | chromosomal instability | 1.23e-03 | 109 | 7 | 2 | MP:0008866 | |
| MousePheno | abnormal chromosome stability | 1.37e-03 | 115 | 7 | 2 | MP:0010094 | |
| MousePheno | failure to gastrulate | 1.47e-03 | 119 | 7 | 2 | MP:0001696 | |
| MousePheno | abnormal intracellular organelle physiology | 1.71e-03 | 532 | 7 | 3 | MP:0014241 | |
| MousePheno | neonatal lethality, complete penetrance | 1.73e-03 | 534 | 7 | 3 | MP:0011087 | |
| MousePheno | abnormal DNA repair | 1.75e-03 | 130 | 7 | 2 | MP:0008058 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 1.89e-03 | 1269 | 7 | 4 | MP:0011111 | |
| Domain | RRM_1 | 3.93e-08 | 208 | 10 | 5 | PF00076 | |
| Domain | RRM | 4.86e-08 | 217 | 10 | 5 | SM00360 | |
| Domain | RRM_dom | 6.09e-08 | 227 | 10 | 5 | IPR000504 | |
| Domain | RRM | 6.50e-08 | 230 | 10 | 5 | PS50102 | |
| Domain | - | 8.73e-08 | 244 | 10 | 5 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.15e-07 | 258 | 10 | 5 | IPR012677 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.33e-07 | 201 | 10 | 5 | MM15411 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.74e-07 | 212 | 10 | 5 | M14033 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 6.57e-07 | 277 | 10 | 5 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 7.30e-07 | 283 | 10 | 5 | M13087 | |
| Pathway | WP_MRNA_PROCESSING | 7.23e-06 | 451 | 10 | 5 | MM15946 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 3.19e-05 | 612 | 10 | 5 | MM15547 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 7.16e-05 | 724 | 10 | 5 | M16843 | |
| Pathway | WP_MRNA_PROCESSING | 7.99e-05 | 126 | 10 | 3 | M39406 | |
| Pathway | REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION | 3.14e-04 | 38 | 10 | 2 | M27820 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 3.84e-04 | 42 | 10 | 2 | M48237 | |
| Pathway | REACTOME_INTERLEUKIN_12_SIGNALING | 4.81e-04 | 47 | 10 | 2 | M27894 | |
| Pathway | REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING | 7.08e-04 | 57 | 10 | 2 | M27381 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 1.95e-03 | 95 | 10 | 2 | M48268 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 2.03e-03 | 97 | 10 | 2 | M48262 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 4.01e-03 | 137 | 10 | 2 | M48232 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 4.30e-03 | 142 | 10 | 2 | M48257 | |
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | 1.58e-10 | 336 | 10 | 6 | 31253590 | |
| Pubmed | 2.11e-10 | 136 | 10 | 5 | 26979993 | ||
| Pubmed | 6.12e-10 | 421 | 10 | 6 | 34650049 | ||
| Pubmed | 6.48e-10 | 425 | 10 | 6 | 24999758 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 6.95e-10 | 430 | 10 | 6 | 38172120 | |
| Pubmed | 7.31e-10 | 174 | 10 | 5 | 35031058 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.28e-09 | 954 | 10 | 7 | 36373674 | |
| Pubmed | LINKIN, a new transmembrane protein necessary for cell adhesion. | 1.34e-09 | 480 | 10 | 6 | 25437307 | |
| Pubmed | Profiling of Parkin-binding partners using tandem affinity purification. | 1.59e-09 | 203 | 10 | 5 | 24244333 | |
| Pubmed | 1.59e-09 | 494 | 10 | 6 | 26831064 | ||
| Pubmed | 1.71e-09 | 206 | 10 | 5 | 22174317 | ||
| Pubmed | 2.17e-09 | 216 | 10 | 5 | 37640791 | ||
| Pubmed | 2.31e-09 | 65 | 10 | 4 | 32521226 | ||
| Pubmed | 3.06e-09 | 551 | 10 | 6 | 34728620 | ||
| Pubmed | 3.99e-09 | 244 | 10 | 5 | 30349055 | ||
| Pubmed | 3.99e-09 | 244 | 10 | 5 | 29884807 | ||
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 4.89e-09 | 254 | 10 | 5 | 28431233 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 5.08e-09 | 256 | 10 | 5 | 24189400 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 5.28e-09 | 258 | 10 | 5 | 37794589 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 5.35e-09 | 605 | 10 | 6 | 28977666 | |
| Pubmed | 5.49e-09 | 260 | 10 | 5 | 36199071 | ||
| Pubmed | 7.94e-09 | 88 | 10 | 4 | 26318153 | ||
| Pubmed | 8.70e-09 | 90 | 10 | 4 | 23151878 | ||
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 1.13e-08 | 96 | 10 | 4 | 25948554 | |
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 1.23e-08 | 98 | 10 | 4 | 21942715 | |
| Pubmed | 1.42e-08 | 713 | 10 | 6 | 29802200 | ||
| Pubmed | 1.57e-08 | 725 | 10 | 6 | 27025967 | ||
| Pubmed | 1.89e-08 | 109 | 10 | 4 | 12226669 | ||
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 1.89e-08 | 333 | 10 | 5 | 32665550 | |
| Pubmed | 2.10e-08 | 340 | 10 | 5 | 24332808 | ||
| Pubmed | 2.26e-08 | 114 | 10 | 4 | 31553912 | ||
| Pubmed | 2.29e-08 | 346 | 10 | 5 | 25324306 | ||
| Pubmed | 2.35e-08 | 115 | 10 | 4 | 17332742 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 2.97e-08 | 807 | 10 | 6 | 22681889 | |
| Pubmed | 4.61e-08 | 136 | 10 | 4 | 21280222 | ||
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 6.31e-08 | 147 | 10 | 4 | 28977470 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 6.48e-08 | 148 | 10 | 4 | 32538781 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 6.55e-08 | 922 | 10 | 6 | 27609421 | |
| Pubmed | 7.44e-08 | 2 | 10 | 2 | 38331110 | ||
| Pubmed | 7.66e-08 | 441 | 10 | 5 | 31239290 | ||
| Pubmed | Proteomic analysis of complexes formed by human topoisomerase I. | 8.45e-08 | 32 | 10 | 3 | 15848144 | |
| Pubmed | 8.76e-08 | 453 | 10 | 5 | 29656893 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 9.66e-08 | 462 | 10 | 5 | 31138677 | |
| Pubmed | 1.04e-07 | 469 | 10 | 5 | 37314180 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.13e-07 | 477 | 10 | 5 | 31300519 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.22e-07 | 1024 | 10 | 6 | 24711643 | |
| Pubmed | 1.31e-07 | 491 | 10 | 5 | 22623428 | ||
| Pubmed | 1.89e-07 | 1103 | 10 | 6 | 34189442 | ||
| Pubmed | Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis. | 2.23e-07 | 3 | 10 | 2 | 23827524 | |
| Pubmed | 2.23e-07 | 3 | 10 | 2 | 28343865 | ||
| Pubmed | Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS. | 2.23e-07 | 3 | 10 | 2 | 30755280 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 2.41e-07 | 1149 | 10 | 6 | 35446349 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 2.48e-07 | 1155 | 10 | 6 | 20360068 | |
| Pubmed | Identification of DeltaNp63alpha protein interactions by mass spectrometry. | 2.94e-07 | 48 | 10 | 3 | 20085233 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 3.03e-07 | 582 | 10 | 5 | 20467437 | |
| Pubmed | 3.35e-07 | 223 | 10 | 4 | 20020773 | ||
| Pubmed | 3.41e-07 | 224 | 10 | 4 | 32941674 | ||
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | 3.54e-07 | 226 | 10 | 4 | 25900982 | |
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | 3.64e-07 | 604 | 10 | 5 | 37616343 | |
| Pubmed | 3.75e-07 | 52 | 10 | 3 | 26265008 | ||
| Pubmed | 3.90e-07 | 1247 | 10 | 6 | 27684187 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 3.93e-07 | 232 | 10 | 4 | 25515538 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | 4.08e-07 | 1257 | 10 | 6 | 37317656 | |
| Pubmed | Characterization of TFG in mus musculus and Caenorhabditis elegans. | 4.46e-07 | 4 | 10 | 2 | 10092511 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 4.84e-07 | 1294 | 10 | 6 | 30804502 | |
| Pubmed | 4.88e-07 | 245 | 10 | 4 | 21182205 | ||
| Pubmed | IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. | 5.24e-07 | 58 | 10 | 3 | 21642987 | |
| Pubmed | 5.32e-07 | 652 | 10 | 5 | 31180492 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 5.40e-07 | 1318 | 10 | 6 | 30463901 | |
| Pubmed | 5.65e-07 | 660 | 10 | 5 | 32780723 | ||
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | 7.09e-07 | 269 | 10 | 4 | 30442662 | |
| Pubmed | 7.63e-07 | 274 | 10 | 4 | 34244482 | ||
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | 7.76e-07 | 704 | 10 | 5 | 32994395 | |
| Pubmed | 7.93e-07 | 707 | 10 | 5 | 19738201 | ||
| Pubmed | 8.15e-07 | 711 | 10 | 5 | 33022573 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 8.19e-07 | 1415 | 10 | 6 | 28515276 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 8.32e-07 | 714 | 10 | 5 | 28302793 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 8.53e-07 | 1425 | 10 | 6 | 30948266 | |
| Pubmed | 9.15e-07 | 1442 | 10 | 6 | 35575683 | ||
| Pubmed | 1.02e-06 | 295 | 10 | 4 | 26209609 | ||
| Pubmed | Dynamic remodelling of human 7SK snRNP controls the nuclear level of active P-TEFb. | 1.12e-06 | 6 | 10 | 2 | 17611602 | |
| Pubmed | 1.39e-06 | 80 | 10 | 3 | 11991638 | ||
| Pubmed | 1.48e-06 | 803 | 10 | 5 | 36517590 | ||
| Pubmed | 1.54e-06 | 809 | 10 | 5 | 32129710 | ||
| Pubmed | 1.56e-06 | 7 | 10 | 2 | 15975576 | ||
| Pubmed | 1.89e-06 | 844 | 10 | 5 | 25963833 | ||
| Pubmed | 1.95e-06 | 347 | 10 | 4 | 16033648 | ||
| Pubmed | 2.08e-06 | 8 | 10 | 2 | 12183049 | ||
| Pubmed | 3.54e-06 | 109 | 10 | 3 | 29511296 | ||
| Pubmed | The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4. | 3.63e-06 | 110 | 10 | 3 | 18307411 | |
| Pubmed | 3.76e-06 | 971 | 10 | 5 | 33306668 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 3.82e-06 | 411 | 10 | 4 | 35182466 | |
| Pubmed | 4.09e-06 | 11 | 10 | 2 | 33469008 | ||
| Pubmed | RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway. | 4.09e-06 | 11 | 10 | 2 | 37142680 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 4.12e-06 | 989 | 10 | 5 | 36424410 | |
| Pubmed | 4.16e-06 | 115 | 10 | 3 | 20000738 | ||
| Pubmed | MICALL2 as a substrate of ubiquitinase TRIM21 regulates tumorigenesis of colorectal cancer. | 4.26e-06 | 116 | 10 | 3 | 36307841 | |
| Pubmed | 4.36e-06 | 425 | 10 | 4 | 21081503 | ||
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | 4.81e-06 | 1021 | 10 | 5 | 26760575 | |
| Pubmed | 4.84e-06 | 121 | 10 | 3 | 34029587 | ||
| Interaction | MYCN interactions | ARID1A HNRNPDL TFG SS18L1 FUS CASC3 HNRNPR HNRNPA2B1 HNRNPA3 | 2.90e-10 | 1373 | 10 | 9 | int:MYCN |
| Interaction | MIR128-1 interactions | 4.40e-10 | 92 | 10 | 5 | int:MIR128-1 | |
| Interaction | EWSR1 interactions | 6.72e-10 | 906 | 10 | 8 | int:EWSR1 | |
| Interaction | CUL2 interactions | 2.00e-09 | 591 | 10 | 7 | int:CUL2 | |
| Interaction | ARIH2 interactions | 2.72e-09 | 314 | 10 | 6 | int:ARIH2 | |
| Interaction | HNRNPC interactions | 3.26e-09 | 634 | 10 | 7 | int:HNRNPC | |
| Interaction | PHB1 interactions | 3.69e-09 | 1123 | 10 | 8 | int:PHB1 | |
| Interaction | DAZL interactions | 4.40e-09 | 145 | 10 | 5 | int:DAZL | |
| Interaction | NEDD8 interactions | 1.04e-08 | 393 | 10 | 6 | int:NEDD8 | |
| Interaction | TAF15 interactions | 1.30e-08 | 408 | 10 | 6 | int:TAF15 | |
| Interaction | SNRPC interactions | 2.04e-08 | 440 | 10 | 6 | int:SNRPC | |
| Interaction | MIR138-1 interactions | 2.45e-08 | 68 | 10 | 4 | int:MIR138-1 | |
| Interaction | TRIM31 interactions | 2.46e-08 | 454 | 10 | 6 | int:TRIM31 | |
| Interaction | RBM45 interactions | 2.63e-08 | 207 | 10 | 5 | int:RBM45 | |
| Interaction | RBMX interactions | 2.70e-08 | 461 | 10 | 6 | int:RBMX | |
| Interaction | MIR9-3 interactions | 2.76e-08 | 70 | 10 | 4 | int:MIR9-3 | |
| Interaction | MIR29B2 interactions | 2.92e-08 | 71 | 10 | 4 | int:MIR29B2 | |
| Interaction | MIR140 interactions | 2.92e-08 | 71 | 10 | 4 | int:MIR140 | |
| Interaction | MIR122 interactions | 2.92e-08 | 71 | 10 | 4 | int:MIR122 | |
| Interaction | CUL1 interactions | 3.06e-08 | 876 | 10 | 7 | int:CUL1 | |
| Interaction | MIR29B1 interactions | 3.27e-08 | 73 | 10 | 4 | int:MIR29B1 | |
| Interaction | MIR18A interactions | 3.27e-08 | 73 | 10 | 4 | int:MIR18A | |
| Interaction | MIR20A interactions | 3.46e-08 | 74 | 10 | 4 | int:MIR20A | |
| Interaction | CAND1 interactions | 3.53e-08 | 894 | 10 | 7 | int:CAND1 | |
| Interaction | MIR15A interactions | 3.65e-08 | 75 | 10 | 4 | int:MIR15A | |
| Interaction | MIR16-1 interactions | 3.85e-08 | 76 | 10 | 4 | int:MIR16-1 | |
| Interaction | MIR199A2 interactions | 3.85e-08 | 76 | 10 | 4 | int:MIR199A2 | |
| Interaction | MIR429 interactions | 3.85e-08 | 76 | 10 | 4 | int:MIR429 | |
| Interaction | MIR7-3 interactions | 3.85e-08 | 76 | 10 | 4 | int:MIR7-3 | |
| Interaction | MIR9-2 interactions | 4.06e-08 | 77 | 10 | 4 | int:MIR9-2 | |
| Interaction | MIR200A interactions | 4.06e-08 | 77 | 10 | 4 | int:MIR200A | |
| Interaction | MIR92A1 interactions | 4.28e-08 | 78 | 10 | 4 | int:MIR92A1 | |
| Interaction | MIR451A interactions | 4.28e-08 | 78 | 10 | 4 | int:MIR451A | |
| Interaction | MIR98 interactions | 4.28e-08 | 78 | 10 | 4 | int:MIR98 | |
| Interaction | MIR222 interactions | 4.51e-08 | 79 | 10 | 4 | int:MIR222 | |
| Interaction | MIR206 interactions | 4.51e-08 | 79 | 10 | 4 | int:MIR206 | |
| Interaction | MIR1-2 interactions | 4.51e-08 | 79 | 10 | 4 | int:MIR1-2 | |
| Interaction | MIR34C interactions | 4.51e-08 | 79 | 10 | 4 | int:MIR34C | |
| Interaction | MIR143 interactions | 4.75e-08 | 80 | 10 | 4 | int:MIR143 | |
| Interaction | MIR145 interactions | 4.99e-08 | 81 | 10 | 4 | int:MIR145 | |
| Interaction | PSPC1 interactions | 5.21e-08 | 515 | 10 | 6 | int:PSPC1 | |
| Interaction | MIR10B interactions | 5.25e-08 | 82 | 10 | 4 | int:MIR10B | |
| Interaction | SNRPB interactions | 5.33e-08 | 517 | 10 | 6 | int:SNRPB | |
| Interaction | MIR106A interactions | 5.51e-08 | 83 | 10 | 4 | int:MIR106A | |
| Interaction | MIR31 interactions | 5.79e-08 | 84 | 10 | 4 | int:MIR31 | |
| Interaction | MIR199A1 interactions | 5.79e-08 | 84 | 10 | 4 | int:MIR199A1 | |
| Interaction | MIR200B interactions | 5.79e-08 | 84 | 10 | 4 | int:MIR200B | |
| Interaction | MIR7-2 interactions | 5.79e-08 | 84 | 10 | 4 | int:MIR7-2 | |
| Interaction | MIR16-2 interactions | 6.07e-08 | 85 | 10 | 4 | int:MIR16-2 | |
| Interaction | MIR107 interactions | 6.07e-08 | 85 | 10 | 4 | int:MIR107 | |
| Interaction | MIR17 interactions | 6.07e-08 | 85 | 10 | 4 | int:MIR17 | |
| Interaction | MIR18B interactions | 6.07e-08 | 85 | 10 | 4 | int:MIR18B | |
| Interaction | MIR93 interactions | 6.07e-08 | 85 | 10 | 4 | int:MIR93 | |
| Interaction | MIR9-1 interactions | 6.07e-08 | 85 | 10 | 4 | int:MIR9-1 | |
| Interaction | MIR20B interactions | 6.36e-08 | 86 | 10 | 4 | int:MIR20B | |
| Interaction | MIR29A interactions | 6.67e-08 | 87 | 10 | 4 | int:MIR29A | |
| Interaction | ITFG1 interactions | 6.90e-08 | 540 | 10 | 6 | int:ITFG1 | |
| Interaction | MIR141 interactions | 6.99e-08 | 88 | 10 | 4 | int:MIR141 | |
| Interaction | MIR138-2 interactions | 6.99e-08 | 88 | 10 | 4 | int:MIR138-2 | |
| Interaction | MIR29C interactions | 7.31e-08 | 89 | 10 | 4 | int:MIR29C | |
| Interaction | SMC5 interactions | 7.63e-08 | 1000 | 10 | 7 | int:SMC5 | |
| Interaction | MIR221 interactions | 7.65e-08 | 90 | 10 | 4 | int:MIR221 | |
| Interaction | MIR92A2 interactions | 7.65e-08 | 90 | 10 | 4 | int:MIR92A2 | |
| Interaction | MIR1-1 interactions | 7.65e-08 | 90 | 10 | 4 | int:MIR1-1 | |
| Interaction | MIR200C interactions | 8.00e-08 | 91 | 10 | 4 | int:MIR200C | |
| Interaction | MIR155 interactions | 8.36e-08 | 92 | 10 | 4 | int:MIR155 | |
| Interaction | MIR214 interactions | 8.74e-08 | 93 | 10 | 4 | int:MIR214 | |
| Interaction | MIR205 interactions | 8.74e-08 | 93 | 10 | 4 | int:MIR205 | |
| Interaction | MIR19B2 interactions | 9.12e-08 | 94 | 10 | 4 | int:MIR19B2 | |
| Interaction | MIRLET7F1 interactions | 9.12e-08 | 94 | 10 | 4 | int:MIRLET7F1 | |
| Interaction | CUL5 interactions | 9.22e-08 | 567 | 10 | 6 | int:CUL5 | |
| Interaction | MIRLET7A2 interactions | 9.93e-08 | 96 | 10 | 4 | int:MIRLET7A2 | |
| Interaction | MIRLET7C interactions | 1.04e-07 | 97 | 10 | 4 | int:MIRLET7C | |
| Interaction | MIR21 interactions | 1.04e-07 | 97 | 10 | 4 | int:MIR21 | |
| Interaction | MIRLET7F2 interactions | 1.04e-07 | 97 | 10 | 4 | int:MIRLET7F2 | |
| Interaction | MIR363 interactions | 1.04e-07 | 97 | 10 | 4 | int:MIR363 | |
| Interaction | SF3A2 interactions | 1.05e-07 | 273 | 10 | 5 | int:SF3A2 | |
| Interaction | UPF1 interactions | 1.06e-07 | 581 | 10 | 6 | int:UPF1 | |
| Interaction | MIR106B interactions | 1.08e-07 | 98 | 10 | 4 | int:MIR106B | |
| Interaction | DCUN1D1 interactions | 1.09e-07 | 275 | 10 | 5 | int:DCUN1D1 | |
| Interaction | MIR128-2 interactions | 1.12e-07 | 99 | 10 | 4 | int:MIR128-2 | |
| Interaction | MIR19A interactions | 1.17e-07 | 100 | 10 | 4 | int:MIR19A | |
| Interaction | MIRLET7B interactions | 1.22e-07 | 101 | 10 | 4 | int:MIRLET7B | |
| Interaction | MIRLET7D interactions | 1.22e-07 | 101 | 10 | 4 | int:MIRLET7D | |
| Interaction | MIR25 interactions | 1.22e-07 | 101 | 10 | 4 | int:MIR25 | |
| Interaction | MIRLET7A3 interactions | 1.27e-07 | 102 | 10 | 4 | int:MIRLET7A3 | |
| Interaction | MIR15B interactions | 1.32e-07 | 103 | 10 | 4 | int:MIR15B | |
| Interaction | MIR7-1 interactions | 1.32e-07 | 103 | 10 | 4 | int:MIR7-1 | |
| Interaction | CELF1 interactions | 1.37e-07 | 288 | 10 | 5 | int:CELF1 | |
| Interaction | MIR34A interactions | 1.37e-07 | 104 | 10 | 4 | int:MIR34A | |
| Interaction | MIR19B1 interactions | 1.37e-07 | 104 | 10 | 4 | int:MIR19B1 | |
| Interaction | HNRNPF interactions | 1.38e-07 | 607 | 10 | 6 | int:HNRNPF | |
| Interaction | MIRLET7E interactions | 1.48e-07 | 106 | 10 | 4 | int:MIRLET7E | |
| Interaction | MIRLET7A1 interactions | 1.60e-07 | 108 | 10 | 4 | int:MIRLET7A1 | |
| Interaction | HNRNPH3 interactions | 1.70e-07 | 301 | 10 | 5 | int:HNRNPH3 | |
| Interaction | MIR34B interactions | 1.72e-07 | 110 | 10 | 4 | int:MIR34B | |
| Interaction | BRD7 interactions | 1.84e-07 | 637 | 10 | 6 | int:BRD7 | |
| Interaction | MIRLET7I interactions | 1.99e-07 | 114 | 10 | 4 | int:MIRLET7I | |
| Interaction | MIRLET7G interactions | 2.21e-07 | 117 | 10 | 4 | int:MIRLET7G | |
| Interaction | GAPDH interactions | 2.84e-07 | 686 | 10 | 6 | int:GAPDH | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 9.14e-03 | 681 | 10 | 2 | chr1p36 | |
| GeneFamily | RNA binding motif containing | 1.18e-08 | 213 | 8 | 5 | 725 | |
| Coexpression | HAY_BONE_MARROW_PRO_B | 4.88e-08 | 304 | 10 | 5 | M39208 | |
| Coexpression | GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_DN | 6.66e-07 | 200 | 10 | 4 | M8297 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | 1.23e-06 | 1144 | 10 | 6 | MM3843 | |
| Coexpression | LAKE_ADULT_KIDNEY_C9_THIN_ASCENDING_LIMB | 2.14e-06 | 268 | 10 | 4 | M39228 | |
| Coexpression | LAKE_ADULT_KIDNEY_C8_DECENDING_THIN_LIMB | 2.47e-06 | 278 | 10 | 4 | M39227 | |
| Coexpression | LAKE_ADULT_KIDNEY_C18_COLLECTING_DUCT_PRINCIPAL_CELLS_MEDULLA | 4.43e-06 | 322 | 10 | 4 | M39237 | |
| Coexpression | LAKE_ADULT_KIDNEY_C10_THIN_ASCENDING_LIMB | 6.37e-06 | 353 | 10 | 4 | M39229 | |
| Coexpression | FISCHER_DREAM_TARGETS | 1.47e-05 | 969 | 10 | 5 | M149 | |
| Coexpression | JIANG_MELANOMA_TRM9_CD8 | 3.06e-05 | 526 | 10 | 4 | M48973 | |
| Coexpression | GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP | 4.90e-05 | 198 | 10 | 3 | M9534 | |
| Coexpression | GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN | 4.97e-05 | 199 | 10 | 3 | M3175 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP | 5.05e-05 | 200 | 10 | 3 | M8312 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP | 5.05e-05 | 200 | 10 | 3 | M8305 | |
| Coexpression | HALLMARK_MYC_TARGETS_V1 | 5.05e-05 | 200 | 10 | 3 | M5926 | |
| Coexpression | GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_DN | 5.05e-05 | 200 | 10 | 3 | M7644 | |
| Coexpression | GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN | 5.05e-05 | 200 | 10 | 3 | M7653 | |
| Coexpression | BIDUS_METASTASIS_UP | 6.79e-05 | 221 | 10 | 3 | M15866 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | 1.18e-04 | 1492 | 10 | 5 | M40023 | |
| Coexpression | TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_2_CELL | 1.26e-04 | 272 | 10 | 3 | M41669 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 2.09e-04 | 323 | 10 | 3 | M9150 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | 2.57e-04 | 911 | 10 | 4 | M40038 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10 | 3.12e-04 | 70 | 10 | 2 | M1033 | |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 3.36e-04 | 380 | 10 | 3 | M41703 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10 | 3.39e-04 | 73 | 10 | 2 | MM1280 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_BASAL | 3.97e-04 | 79 | 10 | 2 | M39048 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS | 3.97e-04 | 79 | 10 | 2 | M40003 | |
| Coexpression | SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP | 4.28e-04 | 82 | 10 | 2 | M9224 | |
| Coexpression | JIANG_MELANOMA_TRM3_CD8 | 4.63e-04 | 424 | 10 | 3 | M48967 | |
| Coexpression | JIANG_MELANOMA_TRM8_CD4 | 4.70e-04 | 426 | 10 | 3 | M48972 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 4.96e-04 | 434 | 10 | 3 | M15150 | |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | 5.06e-04 | 437 | 10 | 3 | M4665 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 5.44e-04 | 448 | 10 | 3 | MM1044 | |
| Coexpression | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C | 5.66e-04 | 454 | 10 | 3 | M19927 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 5.77e-04 | 457 | 10 | 3 | M1613 | |
| Coexpression | FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN | 5.80e-04 | 458 | 10 | 3 | M4785 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | 6.26e-04 | 470 | 10 | 3 | MM1053 | |
| Coexpression | ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN | 7.14e-04 | 106 | 10 | 2 | M9160 | |
| Coexpression | TRAVAGLINI_LUNG_BASOPHIL_MAST_2_CELL | 7.62e-04 | 503 | 10 | 3 | M41690 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S2 | 8.39e-04 | 115 | 10 | 2 | M7995 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_T_CELL_AGEING | 9.62e-04 | 545 | 10 | 3 | MM3785 | |
| Coexpression | LAKE_ADULT_KIDNEY_C23_ENDOTHELIAL_CELLS_AVR | 1.01e-03 | 126 | 10 | 2 | M39242 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | 1.08e-03 | 568 | 10 | 3 | M4023 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | 1.29e-03 | 1394 | 10 | 4 | M9585 | |
| Coexpression | FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL | 1.56e-03 | 644 | 10 | 3 | M41717 | |
| Coexpression | GAUTAM_EYE_CORNEA_FIBROBLASTS | 1.71e-03 | 165 | 10 | 2 | M43617 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_UP | 1.71e-03 | 165 | 10 | 2 | M3000 | |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | 1.74e-03 | 669 | 10 | 3 | M18635 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 1.86e-03 | 685 | 10 | 3 | MM3782 | |
| Coexpression | GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_UP | 1.86e-03 | 172 | 10 | 2 | M2963 | |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN | 1.86e-03 | 172 | 10 | 2 | M17811 | |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN | 1.88e-03 | 173 | 10 | 2 | MM580 | |
| Coexpression | BENPORATH_NOS_TARGETS | 2.01e-03 | 179 | 10 | 2 | M14573 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | 2.02e-03 | 705 | 10 | 3 | M1410 | |
| Coexpression | FERNANDEZ_BOUND_BY_MYC | 2.06e-03 | 181 | 10 | 2 | M3456 | |
| Coexpression | GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN | 2.13e-03 | 184 | 10 | 2 | M6593 | |
| Coexpression | TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL | 2.18e-03 | 724 | 10 | 3 | M41700 | |
| Coexpression | BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP | 2.26e-03 | 190 | 10 | 2 | M18436 | |
| Coexpression | TABULA_MURIS_SENIS_LARGE_INTESTINE_SECRETORY_CELL_AGEING | 2.27e-03 | 734 | 10 | 3 | MM3740 | |
| Coexpression | BENPORATH_SOX2_TARGETS | 2.27e-03 | 734 | 10 | 3 | M3835 | |
| Coexpression | GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_UP | 2.33e-03 | 193 | 10 | 2 | M3549 | |
| Coexpression | GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN | 2.38e-03 | 195 | 10 | 2 | M7382 | |
| Coexpression | GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP | 2.41e-03 | 196 | 10 | 2 | M5862 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 2.43e-03 | 197 | 10 | 2 | M7403 | |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_DN | 2.46e-03 | 198 | 10 | 2 | M9530 | |
| Coexpression | GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN | 2.46e-03 | 198 | 10 | 2 | M6068 | |
| Coexpression | GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP | 2.46e-03 | 198 | 10 | 2 | M6106 | |
| Coexpression | GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP | 2.46e-03 | 198 | 10 | 2 | M5856 | |
| Coexpression | GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN | 2.46e-03 | 198 | 10 | 2 | M7605 | |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_DN | 2.48e-03 | 199 | 10 | 2 | M9744 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_1H_BMDC_DN | 2.48e-03 | 199 | 10 | 2 | M3800 | |
| Coexpression | GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP | 2.48e-03 | 199 | 10 | 2 | M7656 | |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN | 2.48e-03 | 199 | 10 | 2 | M7651 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_DN | 2.48e-03 | 199 | 10 | 2 | M8741 | |
| Coexpression | GSE27786_NKCELL_VS_ERYTHROBLAST_UP | 2.50e-03 | 200 | 10 | 2 | M4853 | |
| Coexpression | GSE24574_NAIVE_VS_TCONV_CD4_TCELL_DN | 2.50e-03 | 200 | 10 | 2 | M8330 | |
| Coexpression | GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP | 2.50e-03 | 200 | 10 | 2 | M5797 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 2.50e-03 | 200 | 10 | 2 | M3188 | |
| Coexpression | GSE339_CD4POS_VS_CD4CD8DN_DC_DN | 2.50e-03 | 200 | 10 | 2 | M5116 | |
| Coexpression | GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP | 2.50e-03 | 200 | 10 | 2 | M6204 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_DN | 2.50e-03 | 200 | 10 | 2 | M5130 | |
| Coexpression | GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP | 2.50e-03 | 200 | 10 | 2 | M3326 | |
| Coexpression | GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN | 2.50e-03 | 200 | 10 | 2 | M6603 | |
| Coexpression | GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP | 2.50e-03 | 200 | 10 | 2 | M5783 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP | 2.50e-03 | 200 | 10 | 2 | M5777 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_DN | 2.50e-03 | 200 | 10 | 2 | M3841 | |
| Coexpression | GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN | 2.50e-03 | 200 | 10 | 2 | M5186 | |
| Coexpression | GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_DN | 2.50e-03 | 200 | 10 | 2 | M7356 | |
| Coexpression | GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 2.50e-03 | 200 | 10 | 2 | M9563 | |
| Coexpression | GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_DN | 2.50e-03 | 200 | 10 | 2 | M7646 | |
| Coexpression | GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN | 2.50e-03 | 200 | 10 | 2 | M6552 | |
| Coexpression | GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN | 2.50e-03 | 200 | 10 | 2 | M6309 | |
| Coexpression | GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN | 2.50e-03 | 200 | 10 | 2 | M6587 | |
| Coexpression | GSE34515_CD16_POS_MONOCYTE_VS_DC_UP | 2.50e-03 | 200 | 10 | 2 | M8765 | |
| Coexpression | GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_DN | 2.50e-03 | 200 | 10 | 2 | M7819 | |
| Coexpression | GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP | 2.50e-03 | 200 | 10 | 2 | M3459 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | 2.51e-03 | 761 | 10 | 3 | M11961 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | 2.75e-03 | 786 | 10 | 3 | M2388 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_GRANULOCYTE_AGEING | 3.13e-03 | 224 | 10 | 2 | MM3836 | |
| Coexpression | OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP | 3.13e-03 | 224 | 10 | 2 | M12383 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 5.00e-06 | 629 | 10 | 5 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.12e-04 | 595 | 10 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 1.44e-04 | 231 | 10 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.85e-04 | 349 | 10 | 3 | gudmap_developingGonad_P2_testes_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.12e-04 | 378 | 10 | 3 | gudmap_developingGonad_e16.5_testes_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | 6.96e-04 | 395 | 10 | 3 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | 7.84e-04 | 989 | 10 | 4 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500 | 9.20e-04 | 435 | 10 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_500 | 9.33e-04 | 437 | 10 | 3 | gudmap_developingGonad_e11.5_testes_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.36e-03 | 498 | 10 | 3 | gudmap_developingGonad_e11.5_testes_k5_1000 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.98e-10 | 199 | 10 | 5 | 5478b78349b5d8d57f30bb650dcbd5fdb84283d6 | |
| ToppCell | droplet-Marrow-BM-1m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-08 | 195 | 10 | 4 | 637b06ef3967b03f7165d102d316e8b7161a817d | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.33e-08 | 197 | 10 | 4 | 7290f05d0b8465637420119941bcbf2fae44a7e4 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.33e-08 | 197 | 10 | 4 | 106b0f9a0425facc634feb7498c9ba2c55edfbf8 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.33e-08 | 197 | 10 | 4 | 31dfd9842410b5c629f39b5130233995dceb0aef | |
| ToppCell | 10x_3'_v3|World / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.49e-08 | 198 | 10 | 4 | aabb8e9b162ae4cb26ea860c99decdbb51e379e1 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.64e-08 | 199 | 10 | 4 | cdee798e3586e4e7a15de598239090a85752ea1e | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.64e-08 | 199 | 10 | 4 | 713dfd8552635645db5e0b5721c64e5c9b4aa06c | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.64e-08 | 199 | 10 | 4 | ea75804c34989c99aab542e6d72617ed144819b6 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.64e-08 | 199 | 10 | 4 | fe3b7d540a644dfc6beea171c809b4d1ba4e188f | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.64e-08 | 199 | 10 | 4 | 8daf945fc93169b0a4fa3ef9f4a87eedd52e314a | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.79e-08 | 200 | 10 | 4 | 0fd9a8730b7dc461ddf4586899d363541e72d8ba | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.79e-08 | 200 | 10 | 4 | 364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.79e-08 | 200 | 10 | 4 | 19a4213f180ac2d29625d140b602a93a74ab3fdd | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.79e-08 | 200 | 10 | 4 | c28d4ca51d2e2a3a22784ee251975f16a55b0297 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.19e-06 | 136 | 10 | 3 | 0185486c39700dd2f72d79be6d283494dd8379c9 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.19e-06 | 136 | 10 | 3 | 3e13dc0634f3b05e9f9e6c3193f843f62e603b78 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.40e-06 | 180 | 10 | 3 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.17e-06 | 186 | 10 | 3 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.17e-06 | 186 | 10 | 3 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.57e-06 | 189 | 10 | 3 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | H1299-infected-SARSCoV1|infected / Cell line, Condition and Strain | 8.70e-06 | 190 | 10 | 3 | f7bfeefc0f30f81710a5ddd979f19b0c910c4a42 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.55e-06 | 196 | 10 | 3 | 6ba02b806d440eed45bad7616bf3b8be57034427 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.70e-06 | 197 | 10 | 3 | b0e2ea81308bce289cb7cbea0e27de1d01afeed2 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.70e-06 | 197 | 10 | 3 | 78122e1fb80e0ac3084dd4f7c551996330a701df | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.85e-06 | 198 | 10 | 3 | 8aa4149d2c1cec73cfd654db093252ec8ec5ef68 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.85e-06 | 198 | 10 | 3 | a1c8e5c332336823c47c04e56b6d7bc8f057c9da | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.00e-05 | 199 | 10 | 3 | be425e9cb90a73289026b1b7cb581e1c02a8985e | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 1.00e-05 | 199 | 10 | 3 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.00e-05 | 199 | 10 | 3 | 8e7f9312dec1e3a92b6a0ccc7baa2d46e89c11f3 | |
| ToppCell | Sepsis-Bac-SEP|Sepsis / Disease, condition lineage and cell class | 1.01e-05 | 200 | 10 | 3 | 1f80e6a49c632b3ba0cdac1225c78e5d6d6d78a5 | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.01e-05 | 200 | 10 | 3 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-05 | 200 | 10 | 3 | 4234bdc70a9941d4bf77148d75bd271e0c114b88 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.01e-05 | 200 | 10 | 3 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Nasal_Brush-Immune-Dendritic_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.44e-05 | 26 | 10 | 2 | e83bba14028e7684beb3dd0ec5ecf8c88245a202 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-4|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.97e-04 | 166 | 10 | 2 | 52293b8a74d46e6161fb6a2e7e86e51fd9e89a5b | |
| ToppCell | Striatum|World / BrainAtlas - Mouse McCarroll V32 | 6.41e-04 | 172 | 10 | 2 | 8da598d209b8a6646b9f4de1aed833f6fcbb9909 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-04 | 172 | 10 | 2 | 6ab4f01098dddb789df298ddf97b3c384405ee6c | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.41e-04 | 172 | 10 | 2 | f2c17c49b375b28ad47dc6cabda62f1c238023dd | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.41e-04 | 172 | 10 | 2 | 7f3d0ef18f5df1ed80498d435b0378ca398c0b88 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.71e-04 | 176 | 10 | 2 | ce85a13e10cf37f5cf38ca8b0bac6701b6d00ffd | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 7.09e-04 | 181 | 10 | 2 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-04 | 181 | 10 | 2 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-04 | 181 | 10 | 2 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-04 | 181 | 10 | 2 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-7|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.17e-04 | 182 | 10 | 2 | af16334fec2c757b03c84cf252d00e92fa81e4cd | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.25e-04 | 183 | 10 | 2 | f20b0d71f857ac35868fd80531050ad8b6091716 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.41e-04 | 185 | 10 | 2 | 42690b95e2e7d56c822211bb1150acb787cfe2e8 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 186 | 10 | 2 | 11929e36d8c9b4c4bc2f5e912f139f474f91ab00 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.65e-04 | 188 | 10 | 2 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.65e-04 | 188 | 10 | 2 | 8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc | |
| ToppCell | facs-BAT-Fat-3m|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-04 | 189 | 10 | 2 | 7ce71f9c81512ed38c804f025908746b4af3aab1 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-04 | 189 | 10 | 2 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-04 | 191 | 10 | 2 | 8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.97e-04 | 192 | 10 | 2 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.14e-04 | 194 | 10 | 2 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | facs-Skin-Telogen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-04 | 194 | 10 | 2 | ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b | |
| ToppCell | facs-Skin-Telogen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-04 | 194 | 10 | 2 | bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6 | |
| ToppCell | E12.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.14e-04 | 194 | 10 | 2 | 4b335e4da58de1cd94194dc4208ce83854e5e50a | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-04 | 194 | 10 | 2 | 4d7fc4d0a55abb3b645116d13a983bbedc55f70c | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 8.22e-04 | 195 | 10 | 2 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.30e-04 | 196 | 10 | 2 | 8faac7fbdee3a9297023c3151ef1751605413e44 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-immature_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.30e-04 | 196 | 10 | 2 | 9a6e4eea19348a6e3379d3b872456ab6280cb74f | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Trm_gut_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.30e-04 | 196 | 10 | 2 | 528622874692d7d65c905738b078ab53acef5846 | |
| ToppCell | Megakaryocytic-erythropoietic-MEP-MEP|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 8.30e-04 | 196 | 10 | 2 | 4e97010185fa9392da8f69e7b2a7395bf063f8ff | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.30e-04 | 196 | 10 | 2 | 3f5bf202c5d8c15072255c133793c8ee6e8d932f | |
| ToppCell | Megakaryocytic-erythropoietic-MEP|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 8.30e-04 | 196 | 10 | 2 | f90e7fe3a7b2fff30d01a25cc500876861c2e4f1 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 8.39e-04 | 197 | 10 | 2 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 8.39e-04 | 197 | 10 | 2 | e666f6580e9a20b5e550f02125706db17eec8510 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 8.39e-04 | 197 | 10 | 2 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.39e-04 | 197 | 10 | 2 | cd54e6ad175529327fa0372033016b3b978dd452 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.39e-04 | 197 | 10 | 2 | 9af431323da6d099459b7360af40e5df998cffbd | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.39e-04 | 197 | 10 | 2 | 037f5f26fa66818baa35846aa96336155e8a6f45 | |
| ToppCell | systemic_lupus_erythematosus-treated|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.47e-04 | 198 | 10 | 2 | 8165ff735095c52994fb5057d89be93cc378b7da | |
| ToppCell | Healthy_donor|World / disease group, cell group and cell class (v2) | 8.47e-04 | 198 | 10 | 2 | 1ed0b50c9754727a05c27b21f3546bf2e37eef7f | |
| ToppCell | CD8+_Memory_T_cell-CV|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.47e-04 | 198 | 10 | 2 | 3d1749f5106f0912f4a74615863853949f52c73d | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 8.47e-04 | 198 | 10 | 2 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | myeloid-CD34+_Monoblast|myeloid / Lineage and Cell class | 8.47e-04 | 198 | 10 | 2 | e26b98a8380e693110a97d8e5a353998f8d67c6d | |
| ToppCell | CV|World / Virus stimulation, Condition and Cluster | 8.47e-04 | 198 | 10 | 2 | 6a28193af35abec5c029129930c2ca6febaafde2 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.47e-04 | 198 | 10 | 2 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.47e-04 | 198 | 10 | 2 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.47e-04 | 198 | 10 | 2 | 039b67ddd0ac529453a364552abca04e67d8417c | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.47e-04 | 198 | 10 | 2 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.47e-04 | 198 | 10 | 2 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.47e-04 | 198 | 10 | 2 | a07307ecc3d86fbcaf7369b7fce60334b7e2dc8f | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.47e-04 | 198 | 10 | 2 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.47e-04 | 198 | 10 | 2 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.47e-04 | 198 | 10 | 2 | cd876fba12ff30b74aa507286cb1f3a867011a92 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.47e-04 | 198 | 10 | 2 | ec115c4a5dbc54206c72140aa0c8d6a7c29c5563 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.56e-04 | 199 | 10 | 2 | dd94e42b62af7cbd69c472681d3c758552694ae2 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Early_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.56e-04 | 199 | 10 | 2 | d67f5ae05daf942fb79f5b962021f37f4e275f4d | |
| ToppCell | lymphoid|World / Lineage, cell class and subclass | 8.56e-04 | 199 | 10 | 2 | bf599721e7109cf9f361e9381544c291920c28be | |
| ToppCell | Healthy/Control|World / Disease group and Cell class | 8.56e-04 | 199 | 10 | 2 | 2623c42b3e79e401a485879b52e8bbcbc581544d | |
| ToppCell | 3'-Adult-Appendix-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.56e-04 | 199 | 10 | 2 | 77bdd3df106c05acc173555ce13243d93c50e94d | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.56e-04 | 199 | 10 | 2 | 99778178e3ec121802db938db8c5475d19b43fec | |
| ToppCell | 3'-Adult-Appendix|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.56e-04 | 199 | 10 | 2 | 32ff62019535ea30059b63a2686c565baa54bfee | |
| ToppCell | 3'-Adult-Appendix-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.56e-04 | 199 | 10 | 2 | d1a3eaef9e84d0572776e8468099d669b8a98ef7 | |
| ToppCell | 3'-Adult-Appendix-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.56e-04 | 199 | 10 | 2 | 7ff034b384f8fa4e027025aa5bf8cb856d793b18 | |
| ToppCell | Enterocyte_Progenitors|World / shred on cell type and cluster | 8.56e-04 | 199 | 10 | 2 | 776bcc887927dea9ebd76ec4338ce2225c319c2c | |
| ToppCell | mild-Lymphocytic|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.56e-04 | 199 | 10 | 2 | 57a429b4c98decbd0bffb67733eaae1f907898a3 | |
| Computational | RNA splicing. | 1.16e-05 | 65 | 8 | 3 | MODULE_183 | |
| Computational | Neighborhood of DNMT1 | 6.94e-05 | 118 | 8 | 3 | MORF_DNMT1 | |
| Computational | Neighborhood of CDC10 | 1.31e-04 | 146 | 8 | 3 | MORF_CDC10 | |
| Computational | Neighborhood of UBE2N | 1.53e-04 | 154 | 8 | 3 | GCM_UBE2N | |
| Computational | Neighborhood of MYST2 | 2.13e-04 | 172 | 8 | 3 | GCM_MYST2 | |
| Computational | Neighborhood of HAT1 | 2.24e-04 | 175 | 8 | 3 | MORF_HAT1 | |
| Computational | Neighborhood of AATF | 3.78e-04 | 209 | 8 | 3 | MORF_AATF | |
| Computational | Neighborhood of ELAC2 | 4.94e-04 | 46 | 8 | 2 | GNF2_ELAC2 | |
| Computational | Neighborhood of XRCC5 | 5.33e-04 | 235 | 8 | 3 | MORF_XRCC5 | |
| Computational | Genes in the cancer module 32. | 5.74e-04 | 241 | 8 | 3 | MODULE_32 | |
| Computational | Neighborhood of DENR | 6.07e-04 | 51 | 8 | 2 | GNF2_DENR | |
| Computational | Neighborhood of EIF3S2 | 6.09e-04 | 246 | 8 | 3 | MORF_EIF3S2 | |
| Computational | Neighborhood of HDAC1 | 6.69e-04 | 254 | 8 | 3 | MORF_HDAC1 | |
| Computational | Neighborhood of DEK | 7.49e-04 | 264 | 8 | 3 | MORF_DEK | |
| Computational | Neighborhood of BUB3 | 8.61e-04 | 277 | 8 | 3 | MORF_BUB3 | |
| Computational | Neighborhood of ESPL1 | 8.68e-04 | 61 | 8 | 2 | MORF_ESPL1 | |
| Computational | Neighborhood of HDAC2 | 8.89e-04 | 280 | 8 | 3 | MORF_HDAC2 | |
| Computational | Neighborhood of SMC1L1 | 8.96e-04 | 62 | 8 | 2 | MORF_SMC1L1 | |
| Computational | Neighborhood of DDX5 | 9.85e-04 | 65 | 8 | 2 | GCM_DDX5 | |
| Computational | Neighborhood of TERF1 | 1.05e-03 | 67 | 8 | 2 | MORF_TERF1 | |
| Computational | Neighborhood of GNB1 | 1.14e-03 | 305 | 8 | 3 | MORF_GNB1 | |
| Computational | Neighborhood of HBP1 | 1.14e-03 | 70 | 8 | 2 | GCM_HBP1 | |
| Computational | Neighborhood of RBBP6 | 1.14e-03 | 70 | 8 | 2 | GNF2_RBBP6 | |
| Computational | Neighborhood of NPM1 | 1.21e-03 | 72 | 8 | 2 | GNF2_NPM1 | |
| Computational | Neighborhood of CDK2 | 1.21e-03 | 72 | 8 | 2 | MORF_CDK2 | |
| Computational | Neighborhood of PCNA | 1.60e-03 | 83 | 8 | 2 | MORF_PCNA | |
| Computational | Neighborhood of RAD23A | 1.67e-03 | 348 | 8 | 3 | MORF_RAD23A | |
| Computational | Neighborhood of APEX1 | 1.96e-03 | 92 | 8 | 2 | GNF2_APEX1 | |
| Computational | Neighborhood of UBE2N | 2.09e-03 | 95 | 8 | 2 | MORF_UBE2N | |
| Computational | Transcription. | 2.13e-03 | 96 | 8 | 2 | MODULE_124 | |
| Computational | Genes in the cancer module 98. | 2.37e-03 | 393 | 8 | 3 | MODULE_98 | |
| Computational | Neighborhood of RRM1 | 2.41e-03 | 102 | 8 | 2 | MORF_RRM1 | |
| Computational | Neighborhood of HDAC1 | 2.79e-03 | 110 | 8 | 2 | GNF2_HDAC1 | |
| Computational | Neighborhood of ZNF198 | 3.15e-03 | 117 | 8 | 2 | GCM_ZNF198 | |
| Computational | Neighborhood of DFFA | 3.82e-03 | 129 | 8 | 2 | GCM_DFFA | |
| Computational | Neighborhood of FBL | 4.48e-03 | 140 | 8 | 2 | MORF_FBL | |
| Computational | Neighborhood of FBL | 4.86e-03 | 146 | 8 | 2 | GNF2_FBL | |
| Computational | Neighborhood of RFC4 | 5.19e-03 | 151 | 8 | 2 | MORF_RFC4 | |
| Computational | Neighborhood of PRKDC | 8.20e-03 | 191 | 8 | 2 | MORF_PRKDC | |
| Computational | Neighborhood of ACP1 | 9.93e-03 | 211 | 8 | 2 | MORF_ACP1 | |
| Computational | Neighborhood of UBE2I | 1.25e-02 | 238 | 8 | 2 | MORF_UBE2I | |
| Computational | Neighborhood of RAN | 1.57e-02 | 268 | 8 | 2 | MORF_RAN | |
| Computational | Neighborhood of SOD1 | 1.68e-02 | 278 | 8 | 2 | MORF_SOD1 | |
| Computational | Neighborhood of CSNK2B | 1.79e-02 | 287 | 8 | 2 | MORF_CSNK2B | |
| Drug | AC1L1AUZ | 4.42e-07 | 157 | 10 | 4 | CID000001160 | |
| Drug | AC1NRA5C | 6.68e-07 | 174 | 10 | 4 | CID005287709 | |
| Drug | AC1L1B55 | 7.16e-07 | 454 | 10 | 5 | CID000001287 | |
| Drug | bromovanin | 1.98e-05 | 127 | 10 | 3 | ctd:C515564 | |
| Drug | Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; HL60; HG-U133A | 7.21e-05 | 196 | 10 | 3 | 2036_DN | |
| Drug | EMCs | 9.67e-05 | 34 | 10 | 2 | CID005091655 | |
| Drug | Buspirone | 1.02e-04 | 622 | 10 | 4 | ctd:D002065 | |
| Disease | autosomal dominant limb-girdle muscular dystrophy type 3 (implicated_via_orthology) | 1.55e-06 | 6 | 10 | 2 | DOID:0110306 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 1.16e-04 | 48 | 10 | 2 | DOID:423 (implicated_via_orthology) | |
| Disease | Amyotrophic Lateral Sclerosis | 1.69e-04 | 58 | 10 | 2 | C0002736 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.05e-03 | 145 | 10 | 2 | DOID:1289 (implicated_via_orthology) | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 1.42e-03 | 169 | 10 | 2 | DOID:3908 (is_marker_for) | |
| Disease | cancer (implicated_via_orthology) | 3.52e-03 | 268 | 10 | 2 | DOID:162 (implicated_via_orthology) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 4.42e-03 | 301 | 10 | 2 | DOID:684 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | 4.76e-03 | 1074 | 10 | 3 | C0006142 | |
| Disease | free androgen index | 6.74e-03 | 374 | 10 | 2 | EFO_0007005 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QGYGNYNSAYGGDQN | 356 | O14979 | |
| GYGQQGQTPYYNQQS | 461 | O14497 | |
| SQQPSYGGQQQSYGQ | 131 | P35637 | |
| QSYGQQQSYNPPQGY | 141 | P35637 | |
| QQSYNPPQGYGQQNQ | 146 | P35637 | |
| QQPLQQGGDYSGNYG | 601 | O43390 | |
| QLQNGYQGNGDYGSY | 211 | Q14678 | |
| YGGVTYYNPAQQQVQ | 661 | O15234 | |
| QYPSQQSYPGQQQGY | 331 | O75177 | |
| QSYPGQQQGYGSAQG | 336 | O75177 | |
| QQQGYGSAQGAPSQY | 341 | O75177 | |
| GSGNYNDFGNYNQQP | 296 | P22626 | |
| GQMYQQYQQQAGYGA | 241 | Q92734 | |
| DFGNYSGQQQSNYGP | 331 | P51991 |